Bank of America’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$542K Buy
38,598
+1,086
+3% +$15.7K ﹤0.01% 4850
2025
Q4
$579K Buy
37,512
+22,932
+157% +$269K ﹤0.01% 4842
2025
Q3
$126K Buy
14,580
+230
+2% +$1.88K ﹤0.01% 6499
2025
Q2
$143K Buy
14,350
+7,295
+103% +$248K ﹤0.01% 6338
2025
Q1
$620K Buy
7,055
+453
+7% +$39.8K ﹤0.01% 5533
2024
Q4
$612K Sell
6,602
-856
-11% -$73.8K ﹤0.01% 5391
2024
Q3
$546K Buy
7,458
+6,911
+1,263% +$446K ﹤0.01% 5429
2024
Q2
$31.8K Buy
547
+292
+115% +$194K ﹤0.01% 6631
2024
Q1
$264K Sell
255
-394
-61% -$301K ﹤0.01% 5738
2023
Q4
$514K Buy
649
+355
+121% +$181K ﹤0.01% 5479
2023
Q3
$140K Buy
294
+114
+63% +$61.7K ﹤0.01% 6099
2023
Q2
$108K Sell
180
-200
-53% -$128K ﹤0.01% 6165
2023
Q1
$268K Buy
380
+164
+76% +$136K ﹤0.01% 5768
2022
Q4
$221K Sell
216
-148
-41% -$107K ﹤0.01% 5854
2022
Q3
$211K Buy
364
+306
+528% +$204K ﹤0.01% 5943
2022
Q2
$32K Sell
58
-59
-50% -$28.2K ﹤0.01% 7022
2022
Q1
$75K Sell
117
-155
-57% -$60.2K ﹤0.01% 7000
2021
Q4
$112K Buy
272
+247
+988% +$125K ﹤0.01% 6830
2021
Q3
$18K Buy
+25
New +$14K ﹤0.01% 7415

Other funds holding JBIO

Bank of America's JBIO Position: Q1 2026 in Review

Bank of America increased its Jade Biosciences (JBIO) stake by 2.9% in Q1 2026, buying an estimated $15.7K and bringing the position to 38,598 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #4850.

Bank of America first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $620K in Q1 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Bank of America held 38,598 shares of Jade Biosciences worth $542K as of Q1 2026.
  • Bank of America bought 1,086 Jade Biosciences shares in Q1 2026, an estimated $15.7K.
  • Jade Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4850 holding.
  • Bank of America first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Jade Biosciences position peaked at $620K in Q1 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.